Blog
Press Releases
Request a Demo
Platform Logins
NaviNet
Eviti Connect
Eviti Advisor
Linkedin
FB
twitter
youtube
Search
Submit
Solutions
Solutions
Overview
Hospitals and Health Systems
Empower Treatment Decisions
Enable High-Quality Care
Validate Treatment Options
NaviNet AllPayer APIs
Practices and Medical Groups
Empower Treatment Decisions
Validate Treatment Options
NaviNet AllPayer APIs
Healthcare Payer Organizations
Lower Costs
Reduce Care Variability
Ensure Appropriate Reimbursement
Reduce Denials and Appeals
Validate Treatments
Improve Provider Relationships
Ensure Secure Information Exchange
Streamline Implementation and Deployment
Minimize Internal Resource Labor
Products
Products
Overview
Eviti
Oncology
Eviti Connect
Clinical Library
Clinical Review Process
Cost Savings
Implementation Process
FAQs & Support Information
Eviti Advisor
Clinical Library
FAQs & Support Information
Autoimmune Diseases
Clinical Review Process
Cost Savings
Implementation Process
Population Health Management
NaviNet
NaviNet Open
Cost Savings
Implementation Process
Security Overview
Frequently Asked Questions
Support Information
Drug Authorizations
Population Health Management
AllPayer Advantage
NaviNet AllPayer APIs
Cost Savings
OPENNMS
Learn More
Resources
Resources
Overview
News & Events
Press Releases
NantHealth in the News
Industry Events
COVID-19 Resources and Information
Insights
Blog
Infographics
Webinars
Videos
Product Information
Brochures
Case Studies
Datasheets
Factsheets
White Papers
About Us
Our Team
Our Core Values
Board of Directors
Events
Investors
Careers
Current Openings
NantHealth
Belfast, Northern Ireland
OpenNMS
Diversity & Inclusion
Benefits
Contact Us
Search
Submit
Home
Solutions
Products
Resources
About Us
Careers
NantHealth
Belfast, Northern Ireland
OpenNMS
Contact Us
Home Page
Stock Information
Stock Price
News & Events
Press Releases
Events & Presentations
Filings & Financials
SEC Filings
Financial Document Library
Corporate Governance
Governance Highlights
Board of Directors
Management Team
Committee Composition
Shareholder Resources
Email Alerts
Information Request
Investor FAQ
Contact Us
Fact Sheet
Press Releases
All
2022
2021
2020
2019
2018
2017
2016
Search Keyword
December 19, 2016
NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9
Read More
December 16, 2016
NantHealth, Inc. Announces Pricing of $100 Million of 5.50% Convertible Notes
Read More
December 15, 2016
NantHealth, Inc. Announces Proposed $100 Million Convertible Notes Offering
Read More
December 13, 2016
NantHealth Expands Adoption of GPS CancerTM with New Florida Genomics Lab License and Successful Adoption by Florida Community Oncologists
Read More
December 13, 2016
NantHealth Added to Nasdaq Biotech Index
Read More
December 8, 2016
NantHealth, NantKwest and NantOmics Announce Availability of GPS Cancer™ and Phase I – III QUILT Trials Through the U.S. National Institutes of Health’s ClinicalTrials.gov
Read More
December 7, 2016
NantHealth And TransMed Systems Partner to Enable and Inform Community Oncologists of the Most Effective Tools and Technologies for Personalized Cancer Treatments Using GPS Cancer™
Read More
December 6, 2016
NantHealth Announces Exclusive Reseller Agreement for GPS Cancer™ with Oncotest-Teva in Israel
Read More
December 5, 2016
NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with Lunatus
Read More
November 7, 2016
NantHealth Reports 76% Increase in Total Q3 Net Revenue 2016 vs 2015, Gross Profit Triples
Read More
Looking for older Press Releases? Check out the full archive here.
«
1
2
...
12
13
14
15
16
»